NeuroOne Medical Technologies Corporation (NMTC)
NeuroOne Medical Technologies Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Eden Prairie, MN, US. The stock last traded at $1.58, down 0.94% on the session, giving a market capitalisation of $13.8M. On trailing twelve-month figures it carries a trailing P/E of -1.82, a net margin of -68.3%. Its beta of 0.64 implies it has historically moved less than the broad market.
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation is most often compared with the following Healthcare names: